340B Lobbying Still on Track for Record Year

Darbin Wofford, a health policy advisor at Third Way, said his organization is urging Congressional Democrats to adopt 340B program reforms.
Lobbying on 340B issues in 2023 remains on track for a record-breaking year, according to recently released congressional lobbying reports. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Program May Lead to Lower Charity Care, Says Drug Industry-Backed AIDS Group

Brandon Macsata
Brandon Macsata, CEO of ADAP Advocacy, said the group plans to publish data from its ongoing study on the 340B program later this year.
Enrollment in the 340B program was linked to diminished spending on charity care, according to preliminary findings from an ongoing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Sandoz Is 28th Drugmaker to Adopt 340B Contract Pharmacy Restrictions

Drugmaker Sandoz, a Novartis spin-off, became the 28th pharmaceutical company to implement 340B contract pharmacy restrictions.
Generic and biosimilar drugmaker Sandoz today became the 28th pharmaceutical company to place conditions on 340B pricing involving drug shipments [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

GSK Loosens 340B Contract Pharmacy Restrictions in Arkansas and Louisiana

GSK headquarters
GSK was one of two drugmakers to issue refunds to 340B covered entities, according to notices posted on a government regulatory site.
GlaxoSmithKline (GSK) today became the fifth drug manufacturer to loosen or end its 340B contract pharmacy restrictions in Arkansas and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Provider-Genentech Lobbying Group Boosts Spending, Adds Members

340B Working Table
340B Working Table, a lobbying group formed by 340B providers and drugmaker Genentech, has increased spending and added new members.
Genentech, Sanford Health, and Carolina Health Centers’ 340B reform group, 340B Working Table, spent $110,000 on lobbying and gained eight [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GSK Adds Drug to Contract Pharmacy Restriction List

GSK headquarters
GSK was one of two drugmakers to issue refunds to 340B covered entities, according to notices posted on a government regulatory site.
GlaxoSmithKline (GSK) recently restricted 340B pricing on Jesduvroq, an anemia treatment, when providers dispense it through contract pharmacies. GSK contractor [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Biocon Announces New NDC for its Lantus Biosimilar

Biocon
Biocon has added a new national drug code for its insulin biosimilar, the drugmaker recently notified 340B providers.
Indian biopharmaceutical manufacturer Biocon Biologics has notified 340B covered entities about a new national drug code (NDC) for insulin glargine-yfgn, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genentech Asks Hospitals to Check 340B Split-Billing Software Settings

Genentech building
Genentech gave advanced notice to 340B hospitals that the drugmaker would implement 340B contract pharmacy restrictions on May 1.
Drug manufacturer Genentech has asked health systems and hospitals about possible 340B program compliance violations involving split-billing software settings. Staff [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Teva Adds Drug to Hospital Contract Pharmacy Restriction Policy

Drugmaker Teva recently added its medication Austedo to its list of drugs under 340B contract pharmacy restrictions for hospitals.
Drug manufacturer Teva this week added a drug to the hospital contract pharmacy restrictions it first implemented in June. The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

340B Dispute Resolution Final Rule Enters Last Stage of Regulatory Review

HHS signage and building
HRSA plans to host a webinar for federal grantees in the days leading up to the 2024 340B recertification period.
A final rule to implement the 340B administrative dispute resolution (ADR) process arrived this week at the last stage of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live